Nipple Fluid Carcinoembryonic Antigen and Prostate-Specific Antigen in Cancer-Bearing and Tumor-Free Breasts PURPOSE: In node-negative patients, of whom up to 30% will recur within 5 years after ...

CODEX2: A novel scoring system for CDX2 loss in colon cancer—Unraveling prognostic insights and therapeutic opportunities. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...

Accurate detection of lymph-node metastases in prostate cancer is an essential component of the approach to treatment. We investigated whether highly lymphotropic superparamagnetic nanoparticles, ...